论文部分内容阅读
去年1—10月,江苏省出口中成药148吨、价值230万美元,同比分别下降31.4％和22.6％;同期中草药出口2719吨,价值1245万美元,分别增长34.1％和16.7％。 中成药出口下降,是由于日、韩和台湾省天然药材行业的崛起。其中成药行业标准化的实施早于我国,加之国内中药厂商没有充分重视在海外销售药品的认证工作,外包装、广告宣传落后于竞争对手。分析认为,中成药出口一蹶不振的局面近期内难有改观。 中草药出口增长,是由于中草药作为天然药材的重要来源,备受欧美国家关注。去年12月底欧盟正式承认中医合法地位,并在欧盟内设立
From January to October last year, 148 tons of proprietary Chinese medicines were exported from Jiangsu Province, worth 2.3 million U.S. dollars, down 31.4% and 22.6% respectively over the same period of the previous year. Meanwhile, the export of Chinese herbal medicines was 2,719 tons and worth 12.45 million U.S. dollars, up 34.1% and 16.7% respectively. The decline in exports of proprietary Chinese medicines is due to the rise of the natural medicinal herbs industry in Japan, South Korea and Taiwan. Among them, the implementation of standardization of Chinese medicine industry was earlier than that of our country. In addition, the domestic traditional Chinese medicine manufacturers did not pay enough attention to the certification of overseas sales of drugs. Outsourcing and advertising lagged behind their competitors. Analysis, the export of Chinese patent medicine sluggish situation difficult to change in the near future. The growth of Chinese herbal medicine exports is due to the fact that Chinese herbal medicine, as an important source of natural medicinal herbs, has drawn the attention of European and American countries. By the end of December last year, the EU officially recognized the legal status of Chinese medicine and established it within the EU